Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

454 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
KSAC, a defined Leishmania antigen, plus adjuvant protects against the virulence of L. major transmitted by its natural vector Phlebotomus duboscqi.
Gomes R, Teixeira C, Oliveira F, Lawyer PG, Elnaiem DE, Meneses C, Goto Y, Bhatia A, Howard RF, Reed SG, Valenzuela JG, Kamhawi S. Gomes R, et al. Among authors: reed sg. PLoS Negl Trop Dis. 2012;6(4):e1610. doi: 10.1371/journal.pntd.0001610. Epub 2012 Apr 3. PLoS Negl Trop Dis. 2012. PMID: 22509423 Free PMC article.
Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasis.
Cecílio P, Pérez-Cabezas B, Fernández L, Moreno J, Carrillo E, Requena JM, Fichera E, Reed SG, Coler RN, Kamhawi S, Oliveira F, Valenzuela JG, Gradoni L, Glueck R, Gupta G, Cordeiro-da-Silva A. Cecílio P, et al. Among authors: reed sg. PLoS Negl Trop Dis. 2017 Nov 27;11(11):e0005951. doi: 10.1371/journal.pntd.0005951. eCollection 2017 Nov. PLoS Negl Trop Dis. 2017. PMID: 29176865 Free PMC article.
A sand fly salivary protein vaccine shows efficacy against vector-transmitted cutaneous leishmaniasis in nonhuman primates.
Oliveira F, Rowton E, Aslan H, Gomes R, Castrovinci PA, Alvarenga PH, Abdeladhim M, Teixeira C, Meneses C, Kleeman LT, Guimarães-Costa AB, Rowland TE, Gilmore D, Doumbia S, Reed SG, Lawyer PG, Andersen JF, Kamhawi S, Valenzuela JG. Oliveira F, et al. Among authors: reed sg. Sci Transl Med. 2015 Jun 3;7(290):290ra90. doi: 10.1126/scitranslmed.aaa3043. Sci Transl Med. 2015. PMID: 26041707
Optimized subunit vaccine protects against experimental leishmaniasis.
Bertholet S, Goto Y, Carter L, Bhatia A, Howard RF, Carter D, Coler RN, Vedvick TS, Reed SG. Bertholet S, et al. Among authors: reed sg. Vaccine. 2009 Nov 23;27(50):7036-45. doi: 10.1016/j.vaccine.2009.09.066. Epub 2009 Sep 26. Vaccine. 2009. PMID: 19786136 Free PMC article.
Design, development and evaluation of rK28-based point-of-care tests for improving rapid diagnosis of visceral leishmaniasis.
Pattabhi S, Whittle J, Mohamath R, El-Safi S, Moulton GG, Guderian JA, Colombara D, Abdoon AO, Mukhtar MM, Mondal D, Esfandiari J, Kumar S, Chun P, Reed SG, Bhatia A. Pattabhi S, et al. Among authors: reed sg. PLoS Negl Trop Dis. 2010 Sep 14;4(9):e822. doi: 10.1371/journal.pntd.0000822. PLoS Negl Trop Dis. 2010. PMID: 20856856 Free PMC article.
KSAC, the first defined polyprotein vaccine candidate for visceral leishmaniasis.
Goto Y, Bhatia A, Raman VS, Liang H, Mohamath R, Picone AF, Vidal SE, Vedvick TS, Howard RF, Reed SG. Goto Y, et al. Among authors: reed sg. Clin Vaccine Immunol. 2011 Jul;18(7):1118-24. doi: 10.1128/CVI.05024-11. Epub 2011 Jun 1. Clin Vaccine Immunol. 2011. PMID: 21632891 Free PMC article.
454 results